Europe Pharmaceutical Plastic Bottles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

The Europe Pharmaceutical Plastic Bottles Market size is estimated at USD 2.08 billion in 2024, and is expected to reach USD 2.43 billion by 2029, growing at a CAGR of 2.48% during the forecast period (2024-2029).

Key Highlights

• The European pharmaceutical industry is constantly changing due to the changes in people's lifestyles. More people are being diagnosed with various illnesses, and governments are putting more money into healthcare. As more people are diagnosed with multiple diseases, the demand for medicines also increases. This includes medications, nutritional supplements, and other health products, which often come in packaging such as plastic bottles.
• Germany is one of the world's most prestigious pharmaceutical research, development, sales, and manufacturing sites, owing to its innovative nature and long-standing reputation as the "world pharmacy" and steadily growing demand for healthcare-related products. The European pharmaceutical market is growing faster than the German economy, driven by demographic shifts, an increase in chronic conditions, and a greater emphasis on preventive and self-medicating measures.
• The increasing demand for healthcare-related products in Germany and Europe, driven by demographic shifts (aging populations), an increase in chronic conditions, and preventive healthcare measures, translates into higher production and consumption of pharmaceuticals. As a result, there's an increased need for packaging materials like plastic bottles to cater to this rising demand.
• However, Europe ranks second behind North America, with over one-third of the global market. China and other Asian-Pacific nations continue to pose a threat, while the increasing demand for quicker production and improved shelf appeal is driving the market forward. Potential challenges to this market include strict regulations on pharmaceutical packaging by European governments, environmental concerns about the use of plastic, and increasing raw material costs.

Europe Pharmaceutical Plastic Bottles Market Trends

The Polyethylene Terephthalate (PET) Segment is Expected to Witness a Significant Growth in the Market

• Polyethylene terephthalate is a transparent, strong, non-toxic, non-cancerous, bio-compatible, and lightweight plastic part of the polyester family. PET is considered a unique plastic used in pharmaceutical plastic bottles. PET protects against CO2, light, and microorganisms. It has been tested and approved by the EU, NSF, and FDA. PET is lightweight, has a very clear appearance, and looks like glass once set. PET is strong, non-reactive, and shatterproof. This makes it easier for pharmaceutical plastic bottles to meet high safety standards.
• Furthermore, the adoption of PET can lead to a reduction in weight as high as 90% compared with glass, which would allow more efficient transport. In the pharmaceutical industry, PET plastic bottles are being used as an alternative to heavy and fragile glass bottles because of their ability to be reused for different liquids.
• In order to help the evolving pharmaceutical sector respond to the impacts of market challenges, ensuring that medicines are protected against all kinds of alteration in properties caused by physical damage, degradation, and biological contamination while, at the same time, benefiting from higher profits, the region's plastic bottles market play a key role.
• According to the GOV.UK, the government of the United Kingdom spent over USD 263.18 billion on health in 2022-2023, compared to USD 215.17 billion in 2017-2018. With more funding allocated to healthcare, there may be an increase in the demand for pharmaceuticals, including medications packaged in PET bottles. As healthcare services expand and improve, there's likely to be a corresponding rise in the need for medicines, contributing to the growth of the pharmaceutical packaging market.

Germany is Expected to Show Significant Growth

• Due to several developments in Germany by solution providers and various end users, plastic packaging solutions are becoming increasingly popular. Consumer perception of "Made in Germany" goods gave plastic packaging companies better performance space in Germany. The German government has implemented several stringent regulations in the plastics packaging sector.
• The German government's emphasis on packaging design for recyclability and the utilization of renewable and recyclable materials is likely to lead to an increase in the need for sustainable packaging solutions, which, in turn, encourage the pharmaceutical sector in Germany and Europe to search for pharmaceutical plastic bottles that fulfill these sustainability criteria.
• Due to its environmental conditions, Germany is the ideal place for R&D and production of high-quality products. In addition, according to the figures provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), Germany leads the way in research and development spending in the pharmaceutical sector, spending EUR 8,466 million (USD 9,037 million), ahead of Switzerland, the United Kingdom, and France. Germany's commitment to R&D in the pharmaceutical sector fosters innovation and the development of new drugs and medical products.
• As pharmaceutical companies invest in research, they may require specialized packaging solutions, such as pharmaceutical plastic bottles, to store and transport their products. This creates a demand for high-quality packaging materials in the market.
• The German packaging industry accounted for about USD 27.08 billion in revenue in 2016. In 2023, it amounted to USD 32.17 billion. A growing packaging industry often means increased investments in research and development. This can lead to innovations in packaging materials, including pharmaceutical plastic bottles. For instance, the development of advanced and environmentally friendly plastic bottle materials is expected to occur, meeting the sustainability demands of the pharmaceutical industry.

Europe Pharmaceutical Plastic Bottles Industry Overview

The European pharmaceutical plastic bottles market is fragmented, with many players like Amcor Group GmbH, Gerresheimer AG, Berry Group Inc., Pretium Packaging, and ALPLA Werke Alwin Lehner GmbH & Co KG. Players have adopted various organic and inorganic strategies to dominate the market, such as new product launches and collaborations.

• May 2024 - Amcor opened its European Innovation Center in Belgium, aiming to collaborate with regional brands and retailers. The center will focus on crafting packaging solutions that enhance consumer experiences and champion environmental sustainability. It will also create advanced packaging that improves the user experience. This could include features like easier-to-use bottles, better seals, or tamper-evident designs, which are crucial for pharmaceuticals.
• February 2023 - Berry Global Healthcare announced the launch of a comprehensive bundle solution designed to assist customers in capitalizing on the increasing demand for child-resistant (CRC) packaging and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicinal products. The Berry Healthcare bundle includes seven different ranges of 28mm Neck PET Bottles in sizes ranging from 20ml to 1000ml, with a wide selection of designs and eight accompanying closures that include tamper-proof and child-resistant capabilities.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support